Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.

Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA.

Breast Cancer Res Treat. 2010 Aug;122(3):661-70. doi: 10.1007/s10549-009-0594-8. Epub 2009 Oct 23.

PMID:
19851860
2.

Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.

Antalis CJ, Uchida A, Buhman KK, Siddiqui RA.

Clin Exp Metastasis. 2011 Dec;28(8):733-41. doi: 10.1007/s10585-011-9405-9. Epub 2011 Jul 9.

PMID:
21744083
3.

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X.

J Exp Clin Cancer Res. 2010 Jul 10;29:92. doi: 10.1186/1756-9966-29-92.

5.

17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.

Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC.

Anticancer Res. 2000 Jan-Feb;20(1A):11-9.

PMID:
10769629
6.

Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.

Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT Jr, LeRoith D, Fontana JA.

J Cell Physiol. 1993 Jun;155(3):556-67.

PMID:
7684042
8.

Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

Ray A, Nkhata KJ, Cleary MP.

Int J Oncol. 2007 Jun;30(6):1499-509.

PMID:
17487372
9.
10.

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

Favoni RE, de Cupis A, Bruno S, Yee D, Ferrera A, Pirani P, Costa A, Decensi A.

Br J Cancer. 1998 Jun;77(12):2138-47.

11.

Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity.

Kourtidis A, Srinivasaiah R, Carkner RD, Brosnan MJ, Conklin DS.

Breast Cancer Res. 2009;11(2):R16. doi: 10.1186/bcr2240. Epub 2009 Mar 19.

12.

Low-density lipoprotein receptor mRNA in human breast cancer cells: influence by PKC modulators.

Stranzl A, Schmidt H, Winkler R, Kostner GM.

Breast Cancer Res Treat. 1997 Feb;42(3):195-205.

PMID:
9065603
13.

[Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].

Lin Y, Wang SM, Huang RP.

Zhonghua Yi Xue Za Zhi. 2005 Jun 1;85(20):1419-23. Chinese.

PMID:
16029657
14.

Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.

Yoshida T, Eguchi H, Nakachi K, Tanimoto K, Higashi Y, Suemasu K, Iino Y, Morishita Y, Hayashi S.

Carcinogenesis. 2000 Dec;21(12):2193-201.

PMID:
11133808
15.
16.

Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients.

Journe F, Durbecq V, Chaboteaux C, Rouas G, Laurent G, Nonclercq D, Sotiriou C, Body JJ, Larsimont D.

Breast Cancer Res Treat. 2009 Jun;115(3):523-35. doi: 10.1007/s10549-008-0094-2. Epub 2008 Jun 19.

PMID:
18563553
18.

Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.

Kremmer T, Pälyi I, Daubner D, Boldizsár M, Vincze B, Paulik E, Sugár J, Pokorny E, Túry E.

Anticancer Res. 1991 Sep-Oct;11(5):1807-13.

PMID:
1768053
19.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

20.

Influence of LDL oxidation on the proliferation of human breast cancer cells.

Chajes V, Mahon M, Kostner GM.

Free Radic Biol Med. 1996;20(1):113-20.

PMID:
8903687

Supplemental Content

Support Center